Response on Share Price and Share Manipulation

Response on Share Price and Share Manipulation

Assuming the analysis is even close to being accurate (and I think it is) then your stock price makes sense. The events coming to fruition depend on the ability to implement a PR and marketing program, wide distribution of the significant advantages of the N-Assay technology to several critical institutions (hospitals, labs, doctors, CDC, Medicare & Medicaid Center, lawyers and insurance companies), the finalization of the several N-Assay panels with a production company, (I think) one more seriously published research paper on the technology, and the "toppling" of the first big "domino" in the form of a sizable commitment from a medical facility. Once that happens everything will be in motion.

Also please note that my analysis was deliberately conservative. Assuming the clear superiority of the product, the added uses in Sepsis, MRSA, Gonorrhea testing, Enterococcus and so forth could easily double the projections. I know it is incredibly frustrating for all us "longs" to be waiting but things seem to be poised finally do do what we hope although it will take a great deal of hard work and some funds.

The thing that offends me is that I look at the patterns in the share price and know that the company is enormously undervalued. That should change soon and I am certainly not going to be selling any shares at this time. There actually shouldn't be that much trading taking place because people who sell now are basically giving away large sums of money in my opinion. But what is also frustrating is that those who have been implementing a strategy to undermine NanoLogix are so transparent at what they are doing. The company is far too strong to give in to those malicious and criminal enemies but it is still absolutely corrupt.

But you can see from the scale of the potential annual revenues why companies who have been feeding on the medical diagnosis "trough" with inferior products that rapidly deteriorate and have significant breakage issues would want to suppress a product and company with which they can't compete on the basis of product quality. I used to think one of the "big" guys would buy NanoLogix at a premium but then I realized that their business model depends on breakage and rapid deterioration of petri dish systems so they can regularly fill new replacement orders.

As I said when I formerly posted on the counter-productive IHub site whose founder was sentenced to prison for using the site to manipulate stock prices, the people who are deliberately using pricing strategies to manipulate NanoLogix shares will ultimately discover they must answer to the company and its shareholders. As the share prices rise there is a group of real investors who are quite interested in pursuing, suing and seeking prosecution for the manipulators. I personally would prefer a more harsh version of "justice" but we will settle for use of all legitimate legal avenues against these people--large and small.

The quality, accuracy, durability and longevity of the NanoLogix system alters their world and they would rather not have NanoLogix around. But the N-Assay and the patented packaging process are "game changers" that will win out. Of course it helps that the CDC and the Center for Medicare and Medicaid are stepping up in ways that create huge incentives for use of the N-Assay.